INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 445m ago
House PTR45m ago
SEC 13F44m ago
Robinhood Chain44m ago

Results

72,389 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$30K
38 sh
Oct 14, 2026
Page 233 of 1810
← PrevNext →
Oct 15, 2026
traded Oct 14, 2026
+1d
SEC Form 4

Evidence

5
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$11K
14 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

4
KR
Kumaraswami RaviPres. Worldwide Field Ops.
RSKDRISKIFIED LTD.
Open-market sale · 10b5-1 plan
SELL$543K
65.0K sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC Form 4

Evidence

4
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
403.4K sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

4
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$275K
1,700 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

4
BS
Boughton SoleilChief Legal Officer
HIMSHims & Hers Health, Inc.
Open-market sale · 10b5-1 plan
SELL$101K
3,461 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

4
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$397K
2,500 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

4
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$290K
1,800 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

4
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$662K
4,200 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

4
EW
Eddy Robert W.Director, President & CEO
BJBJ's Wholesale Club Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$209K
2,000 sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC Form 4

Evidence

4
EW
Eddy Robert W.Director, President & CEO
BJBJ's Wholesale Club Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$105K
1,000 sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC Form 4

Evidence

4
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$529K
3,408 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

3
EW
Eddy Robert W.Director, President & CEO
BJBJ's Wholesale Club Holdings, Inc.
Option exercise · 10b5-1 plan
M—
12.4K sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

3
SA
Smith Philip AndrewDirector, Chief Executive Officer
SNEXStoneX Group Inc.
Option exercise · 10b5-1 plan
M—
45.0K sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC Form 4

Evidence

3
RC
Ray Michael CharlesSVP, Chief Legal Officer
MUMICRON TECHNOLOGY INC
Grant or award · 10b5-1 plan
A—
4,298 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

3
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
160 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

2
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Option exercise · 10b5-1 plan
M$438K
17.3K sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

2
BH
Bhatia Manish HPresident and COO
MUMICRON TECHNOLOGY INC
Grant or award
A—
25.9K sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

2
BH
Bhatia Manish HPresident and COO
MUMICRON TECHNOLOGY INC
Option exercise
M—
24.1K sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

2
BH
Bhatia Manish HPresident and COO
MUMICRON TECHNOLOGY INC
Grant or award
A—
28.8K sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

2
EW
Eddy Robert W.Director, President & CEO
BJBJ's Wholesale Club Holdings, Inc.
Option exercise · 10b5-1 plan
M$211K
12.4K sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

2
BH
Bhatia Manish HPresident and COO
MUMICRON TECHNOLOGY INC
Grant or award
A—
10.1K sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

2
BH
Bhatia Manish HPresident and COO
MUMICRON TECHNOLOGY INC
Option exercise
M—
20.5K sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

2
BH
Bhatia Manish HPresident and COO
MUMICRON TECHNOLOGY INC
Option exercise
M—
24.1K sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

2
HE
Hafer EvanDirector, Founder, 10% Owner
BRCCBRC Inc.
Other acquisition or disposition · 10b5-1 plan
J—
200 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

2
PJ
Prober Charles J.Director
LIFLife360, Inc.
Option exercise · 10b5-1 plan
M$89K
7,930 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

2
BH
Bhatia Manish HPresident and COO
MUMICRON TECHNOLOGY INC
Grant or award
A—
25.9K sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

1
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$114K
700 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

1
HG
Hansen GwennChief Scientific Officer
NRIXNurix Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$36K
1,452 sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC Form 4

Evidence

1
HA
Houston AndrewDirector, Co-CEO, 10% Owner
DBXDROPBOX, INC.
Derivative conversion · 10b5-1 plan
C—
29.5K sh
Oct 12, 2026Oct 15, 2026
traded Oct 12, 2026
+3dSEC Form 4

Evidence

1
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$192K
1,200 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

1
HA
Houston AndrewDirector, Co-CEO, 10% Owner
DBXDROPBOX, INC.
Derivative conversion · 10b5-1 plan
C—
29.5K sh
Oct 12, 2026Oct 15, 2026
traded Oct 12, 2026
+3dSEC Form 4

Evidence

1
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$82K
500 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

1
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$1.14M
31.0K sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

1
Robinhood Markets, Inc.10% Owner
RVIRobinhood Ventures Fund I
Open-market sale · 10b5-1 plan
SELL$110K
4,362 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

1
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$203K
1,300 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

1
Robinhood Markets, Inc.10% Owner
RVIRobinhood Ventures Fund I
Open-market sale · 10b5-1 plan
SELL$114K
4,537 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

0
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise · 10b5-1 plan
M—
17.0K sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

0
HG
Hansen GwennChief Scientific Officer
NRIXNurix Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
1,452 sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC Form 4

Evidence

0
HG
Hansen GwennChief Scientific Officer
NRIXNurix Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$2,701
1,452 sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC Form 4

Evidence